ClinicalTrials.Veeva

Menu

Australia and New Zealand Adult Extracorporeal Membrane Oxygenation (ECMO) Audit 2005

B

Bayside Health

Status

Completed

Conditions

Respiratory Insufficiency
Respiratory Distress Syndrome, Adult
Shock, Cardiogenic

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Extracorporeal membrane oxygenation (ECMO) is a means of artificially performing the function of the human lung and/or heart outside the body. Its use is escalating in a wide range of clinical settings in the adult population without evidence or guidelines to support this practice.

This study involves a nationwide questionnaire which has two components. The initial pilot survey will attempt to identify all institutions currently practicing ECMO or those intending to do so in the future, and are willing to participate in prospective data collection. The second phase will involve a monthly survey of these centres regarding the extent of ECMO use, practice details implemented, and outcome data.

It is hoped that the collection of this information will later assist in the development of guidelines for this expensive and presently unsubstantiated practice, together with the construction of appropriate training programs for staff.

Sex

All

Ages

16+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • Patients receiving ECMO in Australia and New Zealand

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems